What is PBLS's current stock price?

PBLS (Parabilis Medicines, Inc.) is currently trading at $26.33 with a market cap of $3.07B.

What sector is Parabilis Medicines, Inc. in?

Parabilis Medicines, Inc. (PBLS) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

PBLS Parabilis Medicines, Inc.

NASDAQHealthcare

$26.33-1.92%OpenMarket Cap: $3.07B

As of 2026-10-14 14:05

Why PBLS matters now

Parabilis Medicines, Inc. (PBLS) is a US stock in Healthcare. The latest InvestLog snapshot shows $26.33 with -1.92% on the session and $3.07B in market capitalization.

The latest indexable market news headline is "Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis" from GlobeNewsWire.

Latest News

Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous PolyposisGlobeNewsWire · 2026-10-14

Parabilis Medicines (NASDAQ:PBLS) Shares Gap Up – Here’s What HappenedDefense World · 2026-10-01

Parabilis Medicines, Inc. (PBLS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha · 2026-09-16

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare ConferenceGlobeNewsWire · 2026-09-01

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D.GlobeNewsWire · 2026-08-25

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.